Browse By Cell Line Result Page of OvirusTdb
The total number of records retrieved from this search are 9. Click on ID to see further detail.
IDOV_1730 | Virus nameParovirus | Virus strainH-1PV | Virus genome typeDNA | Virus familyParoviridae | Virus genome modificationNone | Virus aloneYes | Virus in combination with drug/radiationNo | Immune gene insertion in viral genomeNo | Source of cell lineATCC | Origin of cell lineHuman neuroblastoma cell line | Cell lineSK-N-MC | Concentration of cell line7.6E+3 cells per well | In-vitro toxicityNA | AssayMTT assay | In-vitro virus concentration0.001 MOI | In-vitro result100% cell survival | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedCell cycle arrest at G2 phase and induction of apoptosis by virus | Immunogenic effectNA | Clinical trialNA | PMID20087864 |
IDOV_1731 | Virus nameParovirus | Virus strainH-1PV | Virus genome typeDNA | Virus familyParoviridae | Virus genome modificationNone | Virus aloneYes | Virus in combination with drug/radiationNo | Immune gene insertion in viral genomeNo | Source of cell lineATCC | Origin of cell lineHuman neuroblastoma cell line | Cell lineSK-N-MC | Concentration of cell line7.6E+3 cells per well | In-vitro toxicityNA | AssayMTT assay | In-vitro virus concentration0.01 MOI | In-vitro result100% cell survival | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedCell cycle arrest at G2 phase and induction of apoptosis by virus | Immunogenic effectNA | Clinical trialNA | PMID20087864 |
IDOV_1732 | Virus nameParovirus | Virus strainH-1PV | Virus genome typeDNA | Virus familyParoviridae | Virus genome modificationNone | Virus aloneYes | Virus in combination with drug/radiationNo | Immune gene insertion in viral genomeNo | Source of cell lineATCC | Origin of cell lineHuman neuroblastoma cell line | Cell lineSK-N-MC | Concentration of cell line7.6E+3 cells per well | In-vitro toxicityNA | AssayMTT assay | In-vitro virus concentration0.1 MOI | In-vitro result50% cell survival | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedCell cycle arrest at G2 phase and induction of apoptosis by virus | Immunogenic effectNA | Clinical trialNA | PMID20087864 |
IDOV_1733 | Virus nameParovirus | Virus strainH-1PV | Virus genome typeDNA | Virus familyParoviridae | Virus genome modificationNone | Virus aloneYes | Virus in combination with drug/radiationNo | Immune gene insertion in viral genomeNo | Source of cell lineATCC | Origin of cell lineHuman neuroblastoma cell line | Cell lineSK-N-MC | Concentration of cell line7.6E+3 cells per well | In-vitro toxicityNA | AssayMTT assay | In-vitro virus concentration1 MOI | In-vitro result30% cell survival | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedCell cycle arrest at G2 phase and induction of apoptosis by virus | Immunogenic effectNA | Clinical trialNA | PMID20087864 |
IDOV_1734 | Virus nameParovirus | Virus strainH-1PV | Virus genome typeDNA | Virus familyParoviridae | Virus genome modificationNone | Virus aloneYes | Virus in combination with drug/radiationNo | Immune gene insertion in viral genomeNo | Source of cell lineATCC | Origin of cell lineHuman neuroblastoma cell line | Cell lineSK-N-MC | Concentration of cell line7.6E+3 cells per well | In-vitro toxicityNA | AssayMTT assay | In-vitro virus concentration5 MOI | In-vitro result20% cell survival | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedCell cycle arrest at G2 phase and induction of apoptosis by virus | Immunogenic effectNA | Clinical trialNA | PMID20087864 |
IDOV_1735 | Virus nameParovirus | Virus strainH-1PV | Virus genome typeDNA | Virus familyParoviridae | Virus genome modificationNone | Virus aloneYes | Virus in combination with drug/radiationNo | Immune gene insertion in viral genomeNo | Source of cell lineATCC | Origin of cell lineHuman neuroblastoma cell line | Cell lineSK-N-MC | Concentration of cell line7.6E+3 cells per well | In-vitro toxicityNA | AssayMTT assay | In-vitro virus concentration10 MOI | In-vitro result20% cell survival | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedCell cycle arrest at G2 phase and induction of apoptosis by virus | Immunogenic effectNA | Clinical trialNA | PMID20087864 |
IDOV_1736 | Virus nameParovirus | Virus strainH-1PV | Virus genome typeDNA | Virus familyParoviridae | Virus genome modificationNone | Virus aloneYes | Virus in combination with drug/radiationNo | Immune gene insertion in viral genomeNo | Source of cell lineATCC | Origin of cell lineHuman neuroblastoma cell line | Cell lineSK-N-MC | Concentration of cell line7.6E+3 cells per well | In-vitro toxicityNA | AssayMTT assay | In-vitro virus concentration50 MOI | In-vitro result1% cell survival | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedCell cycle arrest at G2 phase and induction of apoptosis by virus | Immunogenic effectNA | Clinical trialNA | PMID20087864 |
IDOV_5630 | Virus nameNewcastle disease virus | Virus strainNDV-MK107 | Virus genome typeRNA | Virus familyParamyxoviridae | Virus genome modificationNone | Virus aloneYes | Virus in combination with drug/radiationNo | Immune gene insertion in viral genomeNo | Source of cell lineNA | Origin of cell lineHuman neuroepithelioma cell line | Cell lineSK-N-MC | Concentration of cell line80% confluency | In-vitro toxicityNA | AssayMTT assay | In-vitro virus concentration20 pfu | In-vitro result50% of cancer cell death occurs | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedInduction of apoptosis by virus infection | Immunogenic effectInduction of IFN-Gamma production | Clinical trialNA | PMIDUS7470426 |
IDOV_5850 | Virus nameNewcastle disease virus | Virus strainNDV-PPMK107 | Virus genome typeRNA | Virus familyParamyxoviridae | Virus genome modificationNone | Virus aloneYes | Virus in combination with drug/radiationNo | Immune gene insertion in viral genomeNo | Source of cell lineNA | Origin of cell lineHuman neuroepithelia cancer cell line | Cell lineSK-N-MC | Concentration of cell line80% confluency | In-vitro toxicityNA | AssayNA | In-vitro virus concentration20 pfu | In-vitro result50% cancer cell death | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedNA | Immunogenic effectNA | Clinical trialNA | PMIDUS8105578 |